Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis

CompletedOBSERVATIONAL
Enrollment

600

Participants

Timeline

Start Date

October 27, 2014

Primary Completion Date

September 28, 2018

Study Completion Date

September 28, 2018

Conditions
Rheumatoid Arthritis
Interventions
OTHER

Biobank creation and Pharmacogenetic analysis

Collection of biological samples (blood, serum, plasma) form patient enrolled in the Emilia Romagna rheumatoid arthritis registry and genotyping genomic DNA samples, and assessing the association between genotypes and response to biological drugs, using multivariate and data-mining approaches that includes also clinical and demographic parameters.

Trial Locations (10)

40136

Rheumatology Unit IRCCS Orthopedic Rizzoli Institute, Bologna

Laboratory of Immunorheumatology and Tissue Regeneration IRCC Rizzoli Orthopedic Institute, Bologna

40138

Rheumatology Unit, Internal Medicine Department of Internal Medicine and Nephrology diseases and Aging, Bologna

42123

Division of Rheumatology Azienda Ospedaliera-IRCC S, Reggio Emilia, Reggio Emilia

44124

Medical Genetics Unit, Dept. of Biomedical and Specialty Surgery, Ferrara

Rheumatology Unit S.Anna University Hospital, Ferrara

47121

Rheumatology Unit, Internal Medicine Department Morgagni Hospital, Forlì

47521

Rheumatology Unit, Department of Internal Medicine Buflini Hospital, Cesena

47921

Department of Internal Medicine Infermis' Hospital, Rimini

48100

Unit of Internal Medicine, Medical Internistic Department Ospedale Santa maria delle croci, Ravenna

All Listed Sponsors
collaborator

Regione Emilia Romagna - Italy within PRU-Liberati project

UNKNOWN

lead

Istituto Ortopedico Rizzoli

OTHER

NCT03555240 - Regional Registry-based Biobank Development and Pharmacogenetic Analysis in Rheumatoid Arthritis | Biotech Hunter | Biotech Hunter